BrUOG 387: Phase Ib investigator-initiated trial of a heat shock protein 90 inhibitor (HSP90i) combined with a CDK4/6i in advanced breast cancer progressing on CDK4/6i and in solid tumors with retinoblastoma (Rb)-deficiency (IND163592).

Authors :: El-Deiry, Wafik S.
Graff, Stephanie L.
Azzoli, Christopher G.
Dizon, Don S.
Fenton, Mary Anne
Sikov, William M.
Safran, Howard
Khan, Hina
Khurshid, Humera
Schumacher, Andrew
Zhou, Lanlan
Zhao, Shuai
Seyhan, Attila A.
Ryspayeva, Dinara
Wood, Roxanne
Winer, Arthur
Calleja, Elizabeth Martine
Ross, Eric A.
Source :: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pTPS3167-TPS3167, 1p
Publication Year :: 2023

Full Text Access

Tools